Digestives & Intestinal Remedies - United Kingdom

United Kingdom

Highlights

In the United Kingdom, the revenue generated in the Digestives & Intestinal Remedies market market is estimated to be US$420.10m in 2024.
It is projected to experience an annual growth rate of 3.72% (CAGR 2024-2029).
When compared to other countries worldwide, China leads the market with a revenue of US$4.41bn in 2024.
Considering the population, the per person revenue in the United Kingdom is US$6.18 in 2024.
The United Kingdom has seen a growing trend in the demand for probiotic supplements as a natural remedy for digestive issues.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestives & Intestinal Remedies market in United Kingdom has been experiencing steady growth in recent years.

Customer preferences: Customers in the United Kingdom have shown a growing interest in digestive health and wellness, which has contributed to the increasing demand for Digestives & Intestinal Remedies. This trend can be attributed to a number of factors, including a greater awareness of the importance of gut health and the role it plays in overall well-being. Additionally, an aging population and changing dietary habits have also influenced customer preferences towards products that can help alleviate digestive issues.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in the United Kingdom is the growing popularity of natural and herbal remedies. Consumers are increasingly seeking out products that are made from natural ingredients and have minimal side effects. This trend is in line with the overall shift towards more natural and holistic approaches to health and wellness. As a result, companies in the market are launching new products that cater to this demand, such as herbal teas, probiotics, and dietary supplements.Another trend in the market is the increasing availability of Digestives & Intestinal Remedies in different formats and formulations. Manufacturers are constantly innovating and introducing new products that are more convenient and easier to consume. This includes products in the form of tablets, capsules, powders, and liquid formulations. This variety of options allows consumers to choose the format that best suits their preferences and lifestyle.

Local special circumstances: The United Kingdom has a well-established healthcare system and a high level of consumer awareness when it comes to health and wellness. This creates a favorable environment for the growth of the Digestives & Intestinal Remedies market. Additionally, the country has a large aging population, which is more prone to digestive issues and therefore contributes to the demand for these products.

Underlying macroeconomic factors: The overall economic stability and disposable income levels in the United Kingdom also play a role in the growth of the Digestives & Intestinal Remedies market. As consumers have more discretionary income, they are more likely to spend on products that promote their health and well-being. Additionally, the increasing trend towards self-care and preventive healthcare has also contributed to the growth of the market.In conclusion, the Digestives & Intestinal Remedies market in the United Kingdom is experiencing steady growth due to customer preferences for natural and herbal remedies, the availability of products in different formats, the country's well-established healthcare system, and underlying macroeconomic factors such as economic stability and disposable income levels.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.